Referências

Artigos principais

Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2016 Mar 15;164(6):425-34.Texto completo external link opens in a new windowResumo external link opens in a new window

Spurling GK, Del Mar CB, Dooley L, et al. Delayed antibiotic prescriptions for respiratory infections. Cochrane Database Syst Rev. 2017 Sep 7;(9):CD004417.Texto completo external link opens in a new windowResumo external link opens in a new window

Smith SM, Fahey T, Smucny J, et al. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2017 Jun 19;(6):CD000245.Texto completo external link opens in a new windowResumo external link opens in a new window

Artigos de referência

1. MacFarlane J, Holmes W, Gard P, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax. 2001;56:109-114.Resumo external link opens in a new window

2. Williamson HA Jr. Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract. 1987;25:251-256.Resumo external link opens in a new window

3. Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2016 Mar 15;164(6):425-34.Texto completo external link opens in a new windowResumo external link opens in a new window

4. Gulliford MC, van Staa T, McDermott L, et al. Cluster randomised trial in the general practice research database: 1. electronic decision support to reduce antibiotic prescribing in primary care (eCRT study). Trials. 2011 May 10;12:115.Texto completo external link opens in a new windowResumo external link opens in a new window

5. King DE, Williams WC, Bishop L, et al. Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract. 1996 Jun;42(6):601-5.Resumo external link opens in a new window

6. Wernli D, Emonet S, Schrenzel J, et al. Evaluation of eight cases of confirmed Bordetella bronchiseptica infection and colonization over a 15-year period. Clin Microbiol Infect. 2011 Feb;17(2):201-3.Texto completo external link opens in a new windowResumo external link opens in a new window

7. Jary H, Simpson H, Havens D, et al. Household air pollution and acute lower respiratory infections in adults: a systematic review. PLoS One. 2016 Dec 1;11(12):e0167656.Texto completo external link opens in a new windowResumo external link opens in a new window

8. Chen H, Zhuo Q, Yuan W, et al. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age. Cochrane Database Syst Rev. 2008;(1):CD006090.Texto completo external link opens in a new windowResumo external link opens in a new window

9. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356::i6583.Texto completo external link opens in a new windowResumo external link opens in a new window

10. Ginde AA, Blatchford P, Breese K, et al. High-dose monthly vitamin D for prevention of acute respiratory infection in older long-term care residents: a randomized clinical trial. J Am Geriatr Soc. 2017;65:496-503.Texto completo external link opens in a new windowResumo external link opens in a new window

11. National Institute for Health and Care Excellence. Pneumonia in adults: diagnosis and management. September 2019 [internet publication].Texto completo external link opens in a new window

12. American College of Radiology. ACR appropriateness criteria: hemoptysis. 2019 [internet publication].Texto completo external link opens in a new window

13. Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017 Oct 12;(10):CD007498.Texto completo external link opens in a new windowResumo external link opens in a new window

14. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med. 2001 Mar 20;134(6):521-9.Resumo external link opens in a new window

15. Melbye H, Kongerud J, Vorland L. Reversible airflow limitation in adults with respiratory infection. Eur Resp J. 1994 Jul;7(7):1239-45.Texto completo external link opens in a new windowResumo external link opens in a new window

16. Becker LA, Hom J, Villasis-Keever M, et al. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. Cochrane Database Syst Rev. 2015 Sep 3;(9):CD001726.Texto completo external link opens in a new windowResumo external link opens in a new window

17. National Institute for Health and Care Excellence. Cough (acute): antimicrobial prescribing. February 2019 [internet publication].Texto completo external link opens in a new window

18. Prabhu Shankar S, Chandrashekharan S, Bolmall CS, et al. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study. J Indian Med Assoc. 2010 May;108(5):313-4;316-8;320.Resumo external link opens in a new window

19. Food and Drug Administration. FDA drug safety communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. January 2018 [internet publication].Texto completo external link opens in a new window

20. Tonkin-Crine SK, Tan PS, van Hecke O, et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. Cochrane Database Syst Rev. 2017 Sep 7;(9):CD012252.Texto completo external link opens in a new windowResumo external link opens in a new window

21. Huang DT, Yealy DM, Filbin MR, et al. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N Engl J Med. 2018 Jul 19;379(3):236-49.Texto completo external link opens in a new windowResumo external link opens in a new window

22. Little P, Stuart B, Smith S, et al. Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study. BMJ. 2017 May 22;357:j2148.Texto completo external link opens in a new windowResumo external link opens in a new window

23. de la Poza Abad M, Mas Dalmau G, Moreno Bakedano M, et al; Delayed Antibiotic Prescription Group. Prescription strategies in acute uncomplicated respiratory infections: a randomized clinical trial. JAMA Intern Med. 2016 Jan;176(1):21-9.Texto completo external link opens in a new windowResumo external link opens in a new window

24. Llor C, Bjerrum L. Antibiotic prescribing for acute bronchitis. Expert Rev Anti Infect Ther. 2016 Jul;14(7):633-42.Texto completo external link opens in a new windowResumo external link opens in a new window

25. Spurling GK, Del Mar CB, Dooley L, et al. Delayed antibiotic prescriptions for respiratory infections. Cochrane Database Syst Rev. 2017 Sep 7;(9):CD004417.Texto completo external link opens in a new windowResumo external link opens in a new window

26. Smith SM, Fahey T, Smucny J, et al. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2017 Jun 19;(6):CD000245.Texto completo external link opens in a new windowResumo external link opens in a new window

27. Kraus EM, Pelzl S, Szecsenyi J, et al. Antibiotic prescribing for acute lower respiratory tract infections (LRTI) - guideline adherence in the German primary care setting: an analysis of routine data. PLoS One. 2017 Mar 28;12(3):e0174584.Texto completo external link opens in a new windowResumo external link opens in a new window

28. McCullough AR, Pollack AJ, Plejdrup Hansen M, et al. Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations. Med J Aust. 2017 Jul 17;207(2):65-9.Resumo external link opens in a new window

29. Hay AD, Little P, Harnden A, et al. Effect of oral prednisolone on symptom duration and severity in nonasthmatic adults with acute lower respiratory tract infection: a randomized clinical trial. JAMA. 2017 Aug 22;318(8):721-30. Resumo external link opens in a new window

30. Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract. 1994 Nov;39(5);437-40.Resumo external link opens in a new window

31. Hueston WJ. A comparison of albuterol and erythromycin for the treatment of acute bronchitis. J Fam Pract. 1991 Nov;33(5):476-80.Resumo external link opens in a new window

32. Timmer A, Günther J, Motschall E, et al. Pelargonium sidoides extract for acute respiratory tract infections. Cochrane Database Syst Rev. 2013;(10):CD006323.Texto completo external link opens in a new windowResumo external link opens in a new window

33. Agbabiaka T, Guo R, Ernst E. Pelargonium sidoides for acute bronchitis: A systematic review and meta-analysis. Phytomedicine. 2008;15:378-385.Resumo external link opens in a new window

34. Kamin W, Maydannik V, Malek FA, et al. Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis: a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots. Int J Clin Pharmacol Ther. 2010;48:184-191.Resumo external link opens in a new window

35. Kamin W, Maydannik VG, Malek FA, et al. Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis. Acta Paediatr. 2010;99:537-543.Texto completo external link opens in a new windowResumo external link opens in a new window

36. Matthys H, Lizogub VG, Malek FA, et al. Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides. Curr Med Res Opin. 2010;26:1413-1422.Resumo external link opens in a new window

37. Ding HY, Zhang N-ZW, Chen B, et al. A multicentered, double-blind, randomized controlled trials of Gankeshuangqing Capsule in the treatment of wind-heat syndrome (acute upper respiratory infection or acute bronchitis). Chin J Evid Based Med. 2010;1:14-22.

38. Kemmerich B, Eberhardt R, Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough: a prospective, double-blind, placebo-controlled clinical trial. Arzneimittelforschung. 2006;56:652-660.Resumo external link opens in a new window

39. Cwientzek U, Ottillinger B, Arenberger P. Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. an other ivy leaves extract. Phytomedicine. 2011;18:1105-1109.Resumo external link opens in a new window

40. Fischer J, Dethlefsen U. Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial. Cough. 2013;9:25.Texto completo external link opens in a new windowResumo external link opens in a new window

41. Gillissen A, Wittig T, Ehmen M, et al. A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol® forte in acute bronchitis. Drug Res (Stuttg). 2013;63:19-27.Resumo external link opens in a new window

O uso deste conteúdo está sujeito aos nossos avisos legais